Supriya Lifescience Limited (SUPRIYA.NS)
INR 698.8
(3.55%)
INR 698.8
(3.55%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 2.65 Billion INR | -5.34% |
| 2022 | 2.8 Billion INR | -3.23% |
| 2021 | 2.89 Billion INR | 23.61% |
| 2020 | 2.34 Billion INR | 57.29% |
| 2019 | 1.48 Billion INR | 42.73% |
| 2018 | 1.04 Billion INR | 197.23% |
| 2017 | 350.96 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.2 Billion INR | 9.63% |
| 2024 Q1 | 872.89 Million INR | 10.69% |
| 2023 Q1 | 848.01 Million INR | -10.46% |
| 2023 Q4 | 788.61 Million INR | -7.71% |
| 2023 Q3 | 854.53 Million INR | 8.92% |
| 2023 Q2 | 784.56 Million INR | -7.48% |
| 2023 FY | 2.65 Billion INR | -5.34% |
| 2022 Q4 | 947.09 Million INR | 76.07% |
| 2022 Q3 | 537.92 Million INR | -17.6% |
| 2022 Q2 | 652.8 Million INR | -1.6% |
| 2022 Q1 | 663.42 Million INR | -8.7% |
| 2022 FY | 2.8 Billion INR | -3.23% |
| 2021 Q2 | 1.04 Billion INR | 178.91% |
| 2021 FY | 2.89 Billion INR | 23.61% |
| 2021 Q1 | 373.75 Million INR | -51.39% |
| 2021 Q4 | 726.6 Million INR | -3.39% |
| 2021 Q3 | 752.08 Million INR | -27.85% |
| 2020 Q3 | 479.36 Million INR | 0.0% |
| 2020 FY | 2.34 Billion INR | 57.29% |
| 2020 Q4 | 768.89 Million INR | 60.4% |
| 2019 FY | 1.48 Billion INR | 42.73% |
| 2018 FY | 1.04 Billion INR | 197.23% |
| 2017 FY | 350.96 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Biocon Limited | 91.73 Billion INR | 97.109% |
| Blue Jet Healthcare Limited | 3.15 Billion INR | 16.061% |
| Concord Biotech Limited | 7.56 Billion INR | 64.944% |
| Dishman Carbogen Amcis Limited | 4.9 Billion INR | 45.924% |
| Jubilant Ingrevia Limited | 9.16 Billion INR | 71.069% |
| Lyka Labs Limited | 145.95 Million INR | -1716.899% |
| Panacea Biotec Limited | 1.42 Billion INR | -85.739% |
| Piramal Pharma Limited | 24.47 Billion INR | 89.163% |
| SMS Lifesciences India Limited | 329.57 Million INR | -704.61% |
| Syngene International Limited | 12.43 Billion INR | 78.68% |
| TAKE Solutions Limited | 183.42 Million INR | -1345.753% |
| Zota Health Care Limited | 332.52 Million INR | -697.469% |